The Pfizer COVID-19 vaccine now not wants to be saved at ultra-freezing temperatures and may be safely stored inside regular medical freezers — making distribution simpler, the agency mentioned in a report Friday.
The makers of the pictures, together with the German biotechnology agency BioNTech, have found the doses can stay at between 5 and -13 levels Fahrenheit with out spoiling — as a substitute of -94 levels like beforehand thought, in accordance to the Monetary Instances.
The power to retailer the life-saving jabs at larger temperatures provides vaccine distribution facilities “larger flexibility” and makes them “simpler to transport and use” in rural or hard-to-reach areas, BioNTech’s CEO Ugur Sahin mentioned.
The brand new vaccine “stability knowledge” revealed by the businesses have now been submitted to U.S. Meals and Drug Administration, the paper reported.
Pfizer’s groundbreaking vaccine was the primary to be authorised within the US and Europe final 12 months. However in November, consultants warned that the vaccine may turn into a logistical nightmare to distribute to due to sub-zero storage temperatures.
Corporations concerned in delivery the pictures have since complained additionally that the federal government had failed to contemplate temperature-related the challenges of “final mile” supply.
The need to retailer and transport the vaccine at ultra-freezing temperatures has delayed its rollout, particularly distant areas with out so-called “cold-chain” infrastructure.
Add Comment